Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.

Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA.

J Magn Reson Imaging. 2010 Aug;32(2):360-6. doi: 10.1002/jmri.22271.

PMID:
20677263
2.

Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.

Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.

Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045.

PMID:
18608015
3.

Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.

Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA.

J Magn Reson Imaging. 2013 Apr;37(4):892-902. doi: 10.1002/jmri.23873. Epub 2012 Oct 23.

PMID:
23097278
4.

Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.

Korpraphong P, Leyendecker JR, Hildebolt CF, Narra V, Bae KT, Brown JJ.

J Med Assoc Thai. 2009 Apr;92(4):548-55.

PMID:
19374308
5.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
6.

Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.

Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, John D, Teperman LW, Goldenberg AS.

Liver Transpl. 2002 Dec;8(12):1156-64. Erratum in: Liver Transpl. 2003 Feb;9(2):205.

7.

Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.

Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS.

Liver Transpl. 2005 Mar;11(3):281-9.

8.

Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.

Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.

Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.

PMID:
19838119
9.

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.

Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.

PMID:
20057319
10.

Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.

Scharitzer M, Schima W, Schober E, Reimer P, Helmberger TK, Holzknecht N, Stadler A, Ba-Ssalamah A, Weber M, Wrba F.

J Comput Assist Tomogr. 2005 Mar-Apr;29(2):181-90.

PMID:
15772534
11.

MR features of regenerative nodules and dysplastic nodules in the cirrhotic liver.

Xu H, Kong X, Xiong Y, Zhang X.

J Huazhong Univ Sci Technolog Med Sci. 2005;25(5):601-3.

PMID:
16463687
12.

The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.

Shah TU, Semelka RC, Pamuklar E, Firat Z, Gerber RD, Shrestha R, Russo MW.

Am J Gastroenterol. 2006 Mar;101(3):533-40.

PMID:
16542290
13.

The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.

Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI.

Invest Radiol. 2008 Mar;43(3):202-10. doi: 10.1097/RLI.0b013e31815d6929.

PMID:
18301317
14.

Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J.

Hepatology. 2009 Sep;50(3):791-8. doi: 10.1002/hep.23071.

PMID:
19610049
15.

MRI findings of rapidly progressive hepatocellular carcinoma.

Kierans AS, Leonardou P, Hayashi P, Brubaker LM, Elazzazi M, Shaikh F, Semelka RC.

Magn Reson Imaging. 2010 Jul;28(6):790-6. doi: 10.1016/j.mri.2010.03.005. Epub 2010 Apr 27.

PMID:
20427139
16.

Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma.

Li CS, Chen RC, Lii JM, Chen WT, Shih LS, Zhang TA, Tu HY.

J Comput Assist Tomogr. 2006 Jul-Aug;30(4):597-603.

PMID:
16845290
17.

Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.

Chou CT, Chen YL, Su WW, Wu HK, Chen RC.

J Magn Reson Imaging. 2010 Oct;32(4):895-902. doi: 10.1002/jmri.22316.

PMID:
20882620
18.

Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.

Gatto A, De Gaetano AM, Giuga M, Ciresa M, Siciliani L, Miele L, Riccardi L, Pizzolante F, Rapaccini GL, Gasbarrini A, Giuliante F, Vecchio FM, Pompili M, Bonomo L.

Abdom Imaging. 2013 Aug;38(4):736-44. doi: 10.1007/s00261-012-9950-y.

PMID:
22986351
19.

How to differentiate liver lesions in cirrhosis.

Bartolozzi C, Crocetti L, Della Pina MC.

JBR-BTR. 2007 Nov-Dec;90(6):475-81. Review.

PMID:
18376759
20.

Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.

Lin MT, Chen CL, Wang CC, Cheng YF, Eng HL, Wang JH, Chiu KW, Lee CM, Hu TH.

J Gastroenterol Hepatol. 2011 Apr;26(4):745-50. doi: 10.1111/j.1440-1746.2010.06501.x.

PMID:
21418303
Items per page

Supplemental Content

Write to the Help Desk